Targeting the nucleus: an overview of Auger-electron radionuclide therapy.

Targeting the nucleus: an overview of Auger-electron radionuclide therapy.

The review presented here lays out the present state of the art in the field of radionuclide therapies specifically targeted against the nucleus of cancer cells, focussing on the use of Auger-electron-emitters. Nuclear localisation of radionuclides increases DNA damage and cell kill, and, in the cas...

Bibliografske podrobnosti
Main Authors:	Cornelissen, B, Vallis, K
Format:	Journal article
Jezik:	English
Izdano:	2010

Podobne knjige/članki

Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide
od: Malick Bio Idrissou, et al.
Izdano: (2021-06-01)

Auger electron radionuclide therapy utilising F3 peptide to target the nucleolus
od: Hillyar, C
Izdano: (2015)

Auger electron therapy using In-111-labelled F3 peptide
od: Cornelissen, B, et al.
Izdano: (2011)

Single cell S-value calculations of a stochastic cascade model for Auger-electron emitting radionuclides
od: Vallis, K, et al.
Izdano: (2016)

Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy
od: Terry, S, et al.
Izdano: (2012)

Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy.
od: Terry, S, et al.
Izdano: (2012)

111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.
od: Cornelissen, B, et al.
Izdano: (2012)

111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin
od: Cornelissen, B, et al.
Izdano: (2012)

111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin
od: Cornelissen, B, et al.
Izdano: (2012)

Absorbed dose evaluation of auger electron-emitting radionuclides: impact of input decay spectra on dose point kernels and S-values
od: Falzone, N, et al.
Izdano: (2017)

Moleculary targeted auger electron radiation therapy for breast cancer: A clinical trial.
od: Vallis, K, et al.
Izdano: (2004)

PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview
od: Luca Filippi, et al.
Izdano: (2024-03-01)

Photoresists as a high spatial resolution autoradiography substrate for quantitative mapping of intra- and sub-cellular distribution of Auger electron emitting radionuclides.
od: Falzone, N, et al.
Izdano: (2012)

Targeted radionuclide therapy in combined-modality regimens
od: Gill, M, et al.
Izdano: (2017)

Combination strategies to improve targeted radionuclide therapy
od: Chan, T, et al.
Izdano: (2020)

Subcellular targeting of theranostic radionuclides
od: Bavelaar, B, et al.
Izdano: (2018)

Targeted radionuclide therapy: new advances for improvement of patient management and response
od: Malcolm, J, et al.
Izdano: (2019)

Investigation of Auger Electron Emitting Radionuclides Effects in Therapy Using the Geant4-DNA Toolkit: A Simulation Study
od: Parvin Ahmadi, et al.
Izdano: (2021-06-01)

Towards quantitative intra-nuclear dose mapping of auger emitting radionuclides used for targeted radiotherapy
od: Royle, G
Izdano: (2016)

A brief overview of targeted radionuclide therapy trials in 2022
od: Aidan Healy, et al.
Izdano: (2023-06-01)

Innovative Approach to Producing Palladium-103 for Auger-Emitting Radionuclide Therapy: A Proof-of-Concept Study
od: Aicha Nour Laouameria, et al.
Izdano: (2024-02-01)

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy in an early brain metastasis model
od: Falzone, N, et al.
Izdano: (2018)

Subcellular Targeting of Theranostic Radionuclides
od: Bas M. Bavelaar, et al.
Izdano: (2018-09-01)

Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”
od: Romain Eychenne, et al.
Izdano: (2021-06-01)

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
od: Eline A.M. Ruigrok, et al.
Izdano: (2019-10-01)

Modelling Potential Candidates for Targeted Auger Therapy
od: Conor M. J. Buchanan, et al.
Izdano: (2024-12-01)

The effect of nucleus size on the cell dose in targeted radionuclide therapy – A monte carlo study
od: Ebrahim Kouhkan, et al.
Izdano: (2020-01-01)

The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
od: Jackson, M
Izdano: (2013)

ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
od: Cornelissen, B, et al.
Izdano: (2011)

La-135 as an Auger-electron emitter for targeted internal radiotherapy
od: Fonslet, J, et al.
Izdano: (2017)

Targeting micrometastases: The effect of heterogeneous radionuclide distribution on tumor control probability
od: Falzone, N, et al.
Izdano: (2018)

Augers and auger bits
od: 8096 British Standards Institution

Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters
od: Alexander S. Sobolev, et al.
Izdano: (2018-08-01)

Scanning auger electron microscopy /
od: Prutton, M, et al.
Izdano: (2006)

Imaging the inside of a tumour: a review of radionuclide imaging and theranostics targeting intracellular epitopes.
od: Cornelissen, B
Izdano: (2014)

Combining external beam radiation and radionuclide therapies: rationale, radiobiology, results, and roadblocks
od: Abbott, E, et al.
Izdano: (2021)

Internalization of Auger electron-emitting isotopes into cancer cells: A method for spatial distribution determination of equivalent source terms
od: Vallis, K, et al.
Izdano: (2016)

Radionuclides for Targeted Therapy: Physical Properties
od: Caroline Stokke, et al.
Izdano: (2022-08-01)

Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview
od: Andrea Cimini, et al.
Izdano: (2021-08-01)

Separation of 103Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide 103mRh.
od: Tara Mastren, et al.
Izdano: (2017-01-01)